her2 amplification
Showing 1 - 2 of 2
HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,
Not yet recruiting
- HER2 Mutant Non-small Cell Lung Cancer
- +3 more
- ELVN-002
- +2 more
- (no location specified)
Dec 6, 2022
HER2 Mutation-Related Tumors, HER2 Amplification Trial (ARX788)
Not yet recruiting
- HER2 Mutation-Related Tumors
- HER2 Amplification
- (no location specified)
Aug 23, 2021